Insilico Collaborates with Pfizer to Explore Novel Data and AI System for Target Discovery

 Insilico Collaborates with Pfizer to Explore Novel Data and AI System for Target Discovery

Insilico Collaborates with Pfizer to Explore Novel Data and AI System for Target Discovery

Shots:

  • The companies enter into a research collaboration to utilize Insilico’s ML technology and Pandomics discovery platform with the focus to identify real-world evidence for potential therapeutic targets for multiple diseases
  • The collaboration allows Insilico to advance its target identification system utilizing ML, generative biology methods and synthetic data generation pipelines
  • The agreement enables Pfizer to explore new technologies that aid in identifying targets and biomarkers, leading to breakthrough therapies targeting unmet medical needs

Click here to­ read full press release/ article | Ref: PRNewswire | Image: Alberamonti

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post